FDA approval News
Latest articles and news about FDA approval on AXL Media.
Latest Articles
- New Zealand Researchers Target Global Market with Breakthrough Ketamine Tablet
Published: Apr 14, 2026
Section: Medical News
A team of New Zealand scientists is moving closer to a major medical milestone, developing a slow-release ketamine tablet aimed at treating the 300,000 New Zealanders—and millions...
- Pfizer and Valneva’s New Lyme Vaccine Demonstrates Over 70% Efficacy in Landmark Phase 3 Trial
Published: Apr 10, 2026
Section: Diseases & Conditions
Pharmaceutical partners Pfizer and Valneva announced positive topline results from their Phase 3 VALOR trial for the investigational Lyme disease vaccine, LB6V. The candidate showe...
- Pfizer to Seek FDA Approval for Lyme Disease Vaccine Despite Failing Statistical Goals in Late-Stage Trial
Published: Apr 2, 2026
Section: Health Technology
Pharmaceutical giant Pfizer announced it will pursue regulatory approval for its Lyme disease vaccine candidate, even though the shot missed its primary statistical endpoint in a P...
- FDA Approves Landmark Gene Therapy for Severe LAD-I After Successful UCLA-Led Clinical Trials
Published: Mar 28, 2026
Section: Health
The U.S. Food and Drug Administration has approved Kresladi, the first-ever gene therapy for leukocyte adhesion deficiency-I (LAD-I), a rare and often fatal pediatric immune disord...
- Medtech Sector Enters 2026 With Historic Valuation Discount and Robust Earnings Outlook
Published: Mar 28, 2026
Section: Global Economy
The medical technology and services sector is currently trading at an attractive price-to-earnings ratio of 22.5x, significantly below its pre-pandemic average of 27x. Despite a pe...
- FDA Grants Landmark Approval to Kresladi as First Gene Therapy for Rare Pediatric Immune Disorder LAD-I
Published: Mar 28, 2026
Section: Health
The U.S. Food and Drug Administration has approved Kresladi, a groundbreaking one-time gene therapy developed by Rocket Pharmaceuticals and UCLA researchers for Leukocyte Adhesion...